Abbreviated New Drug Application

From HL7Wiki
(Redirected from ANDA)
Jump to navigation Jump to search

Generic drug applications are called "abbreviated" because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness. Instead, a generic applicant must scientifically demonstrate that its product is bioequivalent (i.e., performs in the same manner as the innovator drug). Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, low cost alternative to the American public.

Additional Regional Definitions and Synonyms

None

External Links

Drugs@FDA Glossary of Terms